ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $250,000 | -56.5% | 7,804 | -41.1% | 0.00% | -50.0% |
| Q1 2017 | $575,000 | -0.7% | 13,245 | +11.9% | 0.00% | 0.0% |
| Q4 2016 | $579,000 | +22.9% | 11,835 | +12.4% | 0.00% | 0.0% |
| Q1 2016 | $471,000 | -15.6% | 10,530 | -37.6% | 0.00% | +100.0% |
| Q2 2015 | $558,000 | +0.4% | 16,882 | +23.8% | 0.00% | -50.0% |
| Q4 2014 | $556,000 | -72.8% | 13,638 | -75.5% | 0.00% | -75.0% |
| Q3 2014 | $2,042,000 | -19.6% | 55,701 | +1.5% | 0.01% | -27.3% |
| Q2 2014 | $2,541,000 | -18.8% | 54,853 | -27.9% | 0.01% | -21.4% |
| Q1 2014 | $3,129,000 | +769.2% | 76,124 | +706.2% | 0.01% | +600.0% |
| Q4 2013 | $360,000 | -4.5% | 9,442 | -40.2% | 0.00% | 0.0% |
| Q3 2013 | $377,000 | +53.3% | 15,801 | +9.1% | 0.00% | 0.0% |
| Q2 2013 | $246,000 | – | 14,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |